nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—Parkinson's disease—Hyoscyamine—pancreatitis	0.84	1	CpDpCtD
Rasagiline—Atrial arrhythmia—Hyoscyamine—pancreatitis	0.00503	0.0547	CcSEcCtD
Rasagiline—Hyperpyrexia—Hyoscyamine—pancreatitis	0.00375	0.0408	CcSEcCtD
Rasagiline—Arrhythmia supraventricular—Hyoscyamine—pancreatitis	0.0036	0.0392	CcSEcCtD
Rasagiline—BCL2—Apoptosis—BNIP3L—pancreatitis	0.00267	0.0393	CbGpPWpGaD
Rasagiline—BCL2—Inflammasomes—HSP90AB1—pancreatitis	0.00259	0.0381	CbGpPWpGaD
Rasagiline—Balance disorder—Hyoscyamine—pancreatitis	0.00255	0.0278	CcSEcCtD
Rasagiline—Blindness—Hyoscyamine—pancreatitis	0.00252	0.0274	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP12—pancreatitis	0.00246	0.0362	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—DUSP10—pancreatitis	0.00228	0.0336	CbGpPWpGaD
Rasagiline—Blepharitis—Hyoscyamine—pancreatitis	0.00227	0.0247	CcSEcCtD
Rasagiline—Keratitis—Hyoscyamine—pancreatitis	0.00215	0.0234	CcSEcCtD
Rasagiline—Paranoia—Hyoscyamine—pancreatitis	0.00205	0.0223	CcSEcCtD
Rasagiline—Mania—Hyoscyamine—pancreatitis	0.00192	0.0209	CcSEcCtD
Rasagiline—Stupor—Hyoscyamine—pancreatitis	0.00187	0.0204	CcSEcCtD
Rasagiline—Laryngospasm—Hyoscyamine—pancreatitis	0.00187	0.0204	CcSEcCtD
Rasagiline—Ventricular fibrillation—Hyoscyamine—pancreatitis	0.00182	0.0198	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—BNIP3L—pancreatitis	0.00177	0.0261	CbGpPWpGaD
Rasagiline—Ageusia—Hyoscyamine—pancreatitis	0.00172	0.0188	CcSEcCtD
Rasagiline—Dysphagia—Propantheline—pancreatitis	0.00171	0.0186	CcSEcCtD
Rasagiline—Extrasystoles—Hyoscyamine—pancreatitis	0.00166	0.0181	CcSEcCtD
Rasagiline—Delirium—Hyoscyamine—pancreatitis	0.00162	0.0177	CcSEcCtD
Rasagiline—Erectile dysfunction—Propantheline—pancreatitis	0.00157	0.0172	CcSEcCtD
Rasagiline—Ventricular extrasystoles—Hyoscyamine—pancreatitis	0.00154	0.0168	CcSEcCtD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00153	0.0225	CbGpPWpGaD
Rasagiline—Dysarthria—Hyoscyamine—pancreatitis	0.00147	0.0161	CcSEcCtD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00142	0.0209	CbGpPWpGaD
Rasagiline—Blood pressure increased—Hyoscyamine—pancreatitis	0.0014	0.0152	CcSEcCtD
Rasagiline—Ventricular tachycardia—Hyoscyamine—pancreatitis	0.0014	0.0152	CcSEcCtD
Rasagiline—Depressed level of consciousness—Hyoscyamine—pancreatitis	0.00135	0.0147	CcSEcCtD
Rasagiline—Photophobia—Hyoscyamine—pancreatitis	0.00131	0.0143	CcSEcCtD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—HSP90AB1—pancreatitis	0.00125	0.0183	CbGpPWpGaD
Rasagiline—Hypertonia—Hyoscyamine—pancreatitis	0.00122	0.0133	CcSEcCtD
Rasagiline—Hyperkinesia—Hyoscyamine—pancreatitis	0.00122	0.0133	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP12—pancreatitis	0.00121	0.0178	CbGpPWpGaD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.00117	0.0172	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—PPP3CA—pancreatitis	0.00115	0.0168	CbGpPWpGaD
Rasagiline—BCL2—Overview of nanoparticle effects—CRP—pancreatitis	0.00115	0.0168	CbGpPWpGaD
Rasagiline—MAOB—Tryptophan metabolism—ALDH2—pancreatitis	0.00114	0.0168	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—DUSP1—pancreatitis	0.00113	0.0166	CbGpPWpGaD
Rasagiline—Eczema—Hyoscyamine—pancreatitis	0.00113	0.0123	CcSEcCtD
Rasagiline—Eye pain—Hyoscyamine—pancreatitis	0.00112	0.0122	CcSEcCtD
Rasagiline—Amnesia—Hyoscyamine—pancreatitis	0.00108	0.0117	CcSEcCtD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00106	0.0156	CbGpPWpGaD
Rasagiline—Osteoarthritis—Hyoscyamine—pancreatitis	0.00101	0.011	CcSEcCtD
Rasagiline—Dry mouth—Propantheline—pancreatitis	0.000992	0.0108	CcSEcCtD
Rasagiline—Psychotic disorder—Hyoscyamine—pancreatitis	0.000989	0.0108	CcSEcCtD
Rasagiline—Confusional state—Propantheline—pancreatitis	0.00098	0.0107	CcSEcCtD
Rasagiline—Urinary retention—Hyoscyamine—pancreatitis	0.000963	0.0105	CcSEcCtD
Rasagiline—Ataxia—Hyoscyamine—pancreatitis	0.000952	0.0104	CcSEcCtD
Rasagiline—Insomnia—Propantheline—pancreatitis	0.000879	0.00958	CcSEcCtD
Rasagiline—Dysphagia—Hyoscyamine—pancreatitis	0.000875	0.00953	CcSEcCtD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.000873	0.0128	CbGpPWpGaD
Rasagiline—Somnolence—Propantheline—pancreatitis	0.000864	0.00941	CcSEcCtD
Rasagiline—Angina pectoris—Hyoscyamine—pancreatitis	0.000853	0.00929	CcSEcCtD
Rasagiline—Constipation—Propantheline—pancreatitis	0.000831	0.00906	CcSEcCtD
Rasagiline—Dysuria—Hyoscyamine—pancreatitis	0.000818	0.00891	CcSEcCtD
Rasagiline—MAOB—Biological oxidations—FDX1—pancreatitis	0.000814	0.012	CbGpPWpGaD
Rasagiline—Erectile dysfunction—Hyoscyamine—pancreatitis	0.000806	0.00878	CcSEcCtD
Rasagiline—Feeling abnormal—Propantheline—pancreatitis	0.000801	0.00873	CcSEcCtD
Rasagiline—BCL2—TP53 Network—MDM2—pancreatitis	0.000797	0.0117	CbGpPWpGaD
Rasagiline—Depression—Hyoscyamine—pancreatitis	0.000778	0.00848	CcSEcCtD
Rasagiline—Urticaria—Propantheline—pancreatitis	0.000772	0.00841	CcSEcCtD
Rasagiline—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.000769	0.00838	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—PTGS2—pancreatitis	0.000769	0.0113	CbGpPWpGaD
Rasagiline—Myocardial infarction—Hyoscyamine—pancreatitis	0.000765	0.00833	CcSEcCtD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—PPARG—pancreatitis	0.00076	0.0112	CbGpPWpGaD
Rasagiline—Conjunctivitis—Hyoscyamine—pancreatitis	0.000759	0.00826	CcSEcCtD
Rasagiline—MAOB—Biological oxidations—ADH4—pancreatitis	0.000757	0.0111	CbGpPWpGaD
Rasagiline—MAOB—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000748	0.011	CbGpPWpGaD
Rasagiline—Sweating—Hyoscyamine—pancreatitis	0.000748	0.00815	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—CXCL8—pancreatitis	0.000745	0.011	CbGpPWpGaD
Rasagiline—BCL2—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NOD2—pancreatitis	0.000744	0.0109	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—PDGFA—pancreatitis	0.000717	0.0105	CbGpPWpGaD
Rasagiline—Hypersensitivity—Propantheline—pancreatitis	0.000716	0.0078	CcSEcCtD
Rasagiline—Asthenia—Propantheline—pancreatitis	0.000698	0.0076	CcSEcCtD
Rasagiline—Hallucination—Hyoscyamine—pancreatitis	0.000697	0.00759	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.000676	0.00994	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—MPO—pancreatitis	0.000664	0.00975	CbGpPWpGaD
Rasagiline—Dizziness—Propantheline—pancreatitis	0.000643	0.007	CcSEcCtD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—BIRC5—pancreatitis	0.000634	0.00931	CbGpPWpGaD
Rasagiline—Vomiting—Propantheline—pancreatitis	0.000618	0.00673	CcSEcCtD
Rasagiline—CYP1A2—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.000615	0.00904	CbGpPWpGaD
Rasagiline—Mental disorder—Hyoscyamine—pancreatitis	0.000614	0.00669	CcSEcCtD
Rasagiline—Rash—Propantheline—pancreatitis	0.000613	0.00668	CcSEcCtD
Rasagiline—Dermatitis—Propantheline—pancreatitis	0.000612	0.00667	CcSEcCtD
Rasagiline—Headache—Propantheline—pancreatitis	0.000609	0.00663	CcSEcCtD
Rasagiline—BCL2—C-MYB transcription factor network—PPP3CA—pancreatitis	0.000608	0.00893	CbGpPWpGaD
Rasagiline—Dysgeusia—Hyoscyamine—pancreatitis	0.000597	0.00651	CcSEcCtD
Rasagiline—Nausea—Propantheline—pancreatitis	0.000578	0.00629	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—DUSP1—pancreatitis	0.000565	0.0083	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—ADH1B—pancreatitis	0.000564	0.00829	CbGpPWpGaD
Rasagiline—Agitation—Hyoscyamine—pancreatitis	0.00056	0.0061	CcSEcCtD
Rasagiline—Vertigo—Hyoscyamine—pancreatitis	0.000548	0.00597	CcSEcCtD
Rasagiline—Syncope—Hyoscyamine—pancreatitis	0.000547	0.00596	CcSEcCtD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—ICAM1—pancreatitis	0.000538	0.00791	CbGpPWpGaD
Rasagiline—Loss of consciousness—Hyoscyamine—pancreatitis	0.000536	0.00584	CcSEcCtD
Rasagiline—Convulsion—Hyoscyamine—pancreatitis	0.000528	0.00576	CcSEcCtD
Rasagiline—BCL2—Direct p53 effectors—CX3CL1—pancreatitis	0.000525	0.00772	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—CCL5—pancreatitis	0.000525	0.00771	CbGpPWpGaD
Rasagiline—Chest pain—Hyoscyamine—pancreatitis	0.000519	0.00566	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—TNF—pancreatitis	0.000519	0.00763	CbGpPWpGaD
Rasagiline—Anxiety—Hyoscyamine—pancreatitis	0.000517	0.00564	CcSEcCtD
Rasagiline—Dry mouth—Hyoscyamine—pancreatitis	0.000508	0.00553	CcSEcCtD
Rasagiline—Confusional state—Hyoscyamine—pancreatitis	0.000502	0.00547	CcSEcCtD
Rasagiline—Shock—Hyoscyamine—pancreatitis	0.00049	0.00533	CcSEcCtD
Rasagiline—Hyperhidrosis—Hyoscyamine—pancreatitis	0.000481	0.00524	CcSEcCtD
Rasagiline—Hypotension—Hyoscyamine—pancreatitis	0.000465	0.00507	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—pancreatitis	0.000459	0.00674	CbGpPWpGaD
Rasagiline—Insomnia—Hyoscyamine—pancreatitis	0.00045	0.0049	CcSEcCtD
Rasagiline—Dyspnoea—Hyoscyamine—pancreatitis	0.000444	0.00483	CcSEcCtD
Rasagiline—Somnolence—Hyoscyamine—pancreatitis	0.000442	0.00482	CcSEcCtD
Rasagiline—Dyspepsia—Hyoscyamine—pancreatitis	0.000438	0.00477	CcSEcCtD
Rasagiline—CYP1A2—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.000437	0.00643	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—pancreatitis	0.000432	0.00635	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000426	0.00627	CbGpPWpGaD
Rasagiline—Constipation—Hyoscyamine—pancreatitis	0.000426	0.00464	CcSEcCtD
Rasagiline—BCL2—Overview of nanoparticle effects—IL6—pancreatitis	0.000419	0.00615	CbGpPWpGaD
Rasagiline—Feeling abnormal—Hyoscyamine—pancreatitis	0.00041	0.00447	CcSEcCtD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP3—pancreatitis	0.00041	0.00602	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—CASP3—pancreatitis	0.00041	0.00602	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—MDM2—pancreatitis	0.000407	0.00598	CbGpPWpGaD
Rasagiline—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.000407	0.00443	CcSEcCtD
Rasagiline—MAOB—Tryptophan metabolism—MDM2—pancreatitis	0.000405	0.00594	CbGpPWpGaD
Rasagiline—BCL2—RXR and RAR heterodimerization with other nuclear receptor—TNF—pancreatitis	0.000404	0.00593	CbGpPWpGaD
Rasagiline—MAOB—Biological oxidations—ALDH2—pancreatitis	0.000398	0.00584	CbGpPWpGaD
Rasagiline—Urticaria—Hyoscyamine—pancreatitis	0.000395	0.00431	CcSEcCtD
Rasagiline—Abdominal pain—Hyoscyamine—pancreatitis	0.000393	0.00429	CcSEcCtD
Rasagiline—Body temperature increased—Hyoscyamine—pancreatitis	0.000393	0.00429	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—IL18—pancreatitis	0.000387	0.00569	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—INS—pancreatitis	0.000387	0.00569	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—CASP3—pancreatitis	0.000378	0.00556	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BIRC5—pancreatitis	0.000378	0.00555	CbGpPWpGaD
Rasagiline—Hypersensitivity—Hyoscyamine—pancreatitis	0.000367	0.00399	CcSEcCtD
Rasagiline—BCL2—Integrated Cancer Pathway—CASP3—pancreatitis	0.000364	0.00536	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—BDKRB2—pancreatitis	0.000364	0.00535	CbGpPWpGaD
Rasagiline—Asthenia—Hyoscyamine—pancreatitis	0.000357	0.00389	CcSEcCtD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.000355	0.00521	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—BIRC5—pancreatitis	0.000354	0.00521	CbGpPWpGaD
Rasagiline—Pruritus—Hyoscyamine—pancreatitis	0.000352	0.00384	CcSEcCtD
Rasagiline—BCL2—IL-3 Signaling Pathway—CXCL8—pancreatitis	0.000349	0.00513	CbGpPWpGaD
Rasagiline—Diarrhoea—Hyoscyamine—pancreatitis	0.000341	0.00371	CcSEcCtD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—pancreatitis	0.000334	0.0049	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.00033	0.00485	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00033	0.00485	CbGpPWpGaD
Rasagiline—Dizziness—Hyoscyamine—pancreatitis	0.000329	0.00359	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—PRSS2—pancreatitis	0.000328	0.00483	CbGpPWpGaD
Rasagiline—Vomiting—Hyoscyamine—pancreatitis	0.000316	0.00345	CcSEcCtD
Rasagiline—Rash—Hyoscyamine—pancreatitis	0.000314	0.00342	CcSEcCtD
Rasagiline—Dermatitis—Hyoscyamine—pancreatitis	0.000314	0.00342	CcSEcCtD
Rasagiline—Headache—Hyoscyamine—pancreatitis	0.000312	0.0034	CcSEcCtD
Rasagiline—BCL2—Corticotropin-releasing hormone—TLR4—pancreatitis	0.000311	0.00457	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—pancreatitis	0.000309	0.00455	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—CXCL8—pancreatitis	0.000301	0.00442	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TNF—pancreatitis	0.000298	0.00438	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—CASP3—pancreatitis	0.000296	0.00435	CbGpPWpGaD
Rasagiline—Nausea—Hyoscyamine—pancreatitis	0.000296	0.00322	CcSEcCtD
Rasagiline—BCL2—EPO signaling pathway—HRAS—pancreatitis	0.000288	0.00424	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—TGFB1—pancreatitis	0.000284	0.00417	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—KRAS—pancreatitis	0.000284	0.00417	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—HGF—pancreatitis	0.000276	0.00405	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—TNF—pancreatitis	0.000275	0.00404	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—ALDH2—pancreatitis	0.000264	0.00388	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000261	0.00383	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—TGFB1—pancreatitis	0.00026	0.00383	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—NRAS—pancreatitis	0.000259	0.00381	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—SPP1—pancreatitis	0.000256	0.00377	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PRSS3—pancreatitis	0.000249	0.00366	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—TNF—pancreatitis	0.000247	0.00363	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.000246	0.00361	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—INS—pancreatitis	0.000244	0.00359	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—MDM2—pancreatitis	0.000243	0.00357	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—PDGFA—pancreatitis	0.000239	0.00351	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000238	0.00349	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—PTGS2—pancreatitis	0.000234	0.00344	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—HRAS—pancreatitis	0.000232	0.00341	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—HRAS—pancreatitis	0.000223	0.00328	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—KRAS—pancreatitis	0.000223	0.00328	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MET—pancreatitis	0.000218	0.0032	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—pancreatitis	0.000217	0.00319	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HGF—pancreatitis	0.000216	0.00318	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNF—pancreatitis	0.000215	0.00317	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CXCL8—pancreatitis	0.000211	0.0031	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—HRAS—pancreatitis	0.000205	0.00301	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CASP3—pancreatitis	0.000204	0.00299	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—MDM2—pancreatitis	0.000203	0.00298	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP3—pancreatitis	0.000202	0.00297	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—SPP1—pancreatitis	0.000201	0.00295	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—pancreatitis	0.000199	0.00292	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MDM2—pancreatitis	0.000197	0.0029	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRSS2—pancreatitis	0.000191	0.00281	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CXCL8—pancreatitis	0.00019	0.00279	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—HRAS—pancreatitis	0.00019	0.00279	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—FDX1—pancreatitis	0.000188	0.00277	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL1B—pancreatitis	0.000182	0.00268	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—NRAS—pancreatitis	0.000182	0.00268	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—HRAS—pancreatitis	0.000177	0.0026	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HSP90AB1—pancreatitis	0.000176	0.00259	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—ADH4—pancreatitis	0.000175	0.00257	CbGpPWpGaD
Rasagiline—CYP1A2—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.000173	0.00255	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MET—pancreatitis	0.00017	0.0025	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—IL6—pancreatitis	0.000169	0.00249	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTSL—pancreatitis	0.000165	0.00242	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MDM2—pancreatitis	0.000161	0.00237	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—CTRB2—pancreatitis	0.000161	0.00236	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—pancreatitis	0.000158	0.00232	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—TGFB1—pancreatitis	0.000157	0.00231	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—LPL—pancreatitis	0.000157	0.00231	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—KRAS—pancreatitis	0.000157	0.0023	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MDM2—pancreatitis	0.000152	0.00223	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—NRAS—pancreatitis	0.000148	0.00217	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000146	0.00215	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PRSS3—pancreatitis	0.000145	0.00213	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TGFB1—pancreatitis	0.000142	0.00208	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR3—pancreatitis	0.000139	0.00205	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—FDX1—pancreatitis	0.000139	0.00205	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TGFB1—pancreatitis	0.000137	0.00202	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP3—pancreatitis	0.000136	0.002	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HRAS—pancreatitis	0.000133	0.00196	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—pancreatitis	0.000133	0.00196	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CTSB—pancreatitis	0.000133	0.00195	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—ADH1B—pancreatitis	0.000131	0.00192	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PPP3CA—pancreatitis	0.00013	0.00191	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ADH4—pancreatitis	0.000129	0.0019	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—KRAS—pancreatitis	0.000127	0.00187	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	0.000126	0.00185	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—DUSP6—pancreatitis	0.000124	0.00182	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PRSS1—pancreatitis	0.000122	0.00179	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	0.000121	0.00178	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR2—pancreatitis	0.000116	0.0017	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PRSS3—pancreatitis	0.000115	0.0017	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PNLIP—pancreatitis	0.000115	0.0017	CbGpPWpGaD
Rasagiline—BCL2—Immune System—SELL—pancreatitis	0.000113	0.00166	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	0.000113	0.00165	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—HRAS—pancreatitis	0.000111	0.00164	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—HRAS—pancreatitis	0.000108	0.00159	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IL6—pancreatitis	0.000107	0.00157	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NOD2—pancreatitis	0.000105	0.00154	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD14—pancreatitis	0.000104	0.00154	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—XDH—pancreatitis	0.000103	0.00152	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HSP90AB1—pancreatitis	0.000103	0.00151	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PDGFA—pancreatitis	9.81e-05	0.00144	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—KRAS—pancreatitis	9.8e-05	0.00144	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNF—pancreatitis	9.68e-05	0.00142	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ADH1B—pancreatitis	9.65e-05	0.00142	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSL—pancreatitis	9.58e-05	0.00141	CbGpPWpGaD
Rasagiline—CYP1A2—Tryptophan metabolism—MDM2—pancreatitis	9.36e-05	0.00138	CbGpPWpGaD
Rasagiline—CYP1A2—Biological oxidations—ALDH2—pancreatitis	9.2e-05	0.00135	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatitis	9.03e-05	0.00133	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	8.77e-05	0.00129	CbGpPWpGaD
Rasagiline—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatitis	8.44e-05	0.00124	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—pancreatitis	8.4e-05	0.00123	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	8.19e-05	0.0012	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR3—pancreatitis	8.12e-05	0.00119	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	8.12e-05	0.00119	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CTSB—pancreatitis	7.73e-05	0.00114	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PLA2G1B—pancreatitis	7.7e-05	0.00113	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PPP3CA—pancreatitis	7.58e-05	0.00111	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CRP—pancreatitis	7.47e-05	0.0011	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—A2M—pancreatitis	7.43e-05	0.00109	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	7.23e-05	0.00106	CbGpPWpGaD
Rasagiline—BCL2—Immune System—DUSP6—pancreatitis	7.2e-05	0.00106	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—TLR4—pancreatitis	7.16e-05	0.00105	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	7.02e-05	0.00103	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HRAS—pancreatitis	6.93e-05	0.00102	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALDH2—pancreatitis	6.8e-05	0.000999	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR2—pancreatitis	6.75e-05	0.000992	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatitis	6.53e-05	0.000959	CbGpPWpGaD
Rasagiline—BCL2—Immune System—EGR1—pancreatitis	6.27e-05	0.000921	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NOD2—pancreatitis	6.12e-05	0.0009	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	6.09e-05	0.000895	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatitis	6.09e-05	0.000895	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD14—pancreatitis	6.09e-05	0.000894	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	6.04e-05	0.000888	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	5.99e-05	0.000881	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-DQA1—pancreatitis	5.86e-05	0.000861	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PDGFA—pancreatitis	5.71e-05	0.00084	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—MDM2—pancreatitis	5.2e-05	0.000764	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL18—pancreatitis	5.2e-05	0.000763	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HGF—pancreatitis	5.18e-05	0.000761	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GCG—pancreatitis	5.15e-05	0.000757	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	5.14e-05	0.000755	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CRP—pancreatitis	4.35e-05	0.000639	CbGpPWpGaD
Rasagiline—BCL2—Immune System—TLR4—pancreatitis	4.17e-05	0.000613	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HLA-DRB1—pancreatitis	4.17e-05	0.000612	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—LPL—pancreatitis	4.04e-05	0.000594	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	4e-05	0.000588	CbGpPWpGaD
Rasagiline—BCL2—Immune System—ICAM1—pancreatitis	4e-05	0.000588	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—NRAS—pancreatitis	3.9e-05	0.000573	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	3.86e-05	0.000568	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—CTRB2—pancreatitis	3.72e-05	0.000546	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—KRAS—pancreatitis	3.35e-05	0.000493	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—FDX1—pancreatitis	3.22e-05	0.000473	CbGpPWpGaD
Rasagiline—BCL2—Immune System—MDM2—pancreatitis	3.03e-05	0.000445	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADH4—pancreatitis	3e-05	0.00044	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPARG—pancreatitis	2.95e-05	0.000434	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—INS—pancreatitis	2.9e-05	0.000425	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HRAS—pancreatitis	2.85e-05	0.000419	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PRSS1—pancreatitis	2.82e-05	0.000414	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IL6—pancreatitis	2.73e-05	0.000401	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL1B—pancreatitis	2.71e-05	0.000399	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PNLIP—pancreatitis	2.67e-05	0.000392	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PRSS3—pancreatitis	2.67e-05	0.000392	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—ALB—pancreatitis	2.65e-05	0.00039	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—XDH—pancreatitis	2.39e-05	0.000352	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PTGS2—pancreatitis	2.32e-05	0.000341	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NRAS—pancreatitis	2.27e-05	0.000334	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ADH1B—pancreatitis	2.23e-05	0.000328	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	2.1e-05	0.000309	CbGpPWpGaD
Rasagiline—BCL2—Immune System—KRAS—pancreatitis	1.95e-05	0.000287	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PLA2G1B—pancreatitis	1.78e-05	0.000262	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—A2M—pancreatitis	1.72e-05	0.000253	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HRAS—pancreatitis	1.66e-05	0.000244	CbGpPWpGaD
Rasagiline—BCL2—Immune System—IL6—pancreatitis	1.59e-05	0.000234	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALDH2—pancreatitis	1.57e-05	0.000231	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	1.53e-05	0.000225	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	1.38e-05	0.000203	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.21e-05	0.000177	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GCG—pancreatitis	1.19e-05	0.000175	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—LPL—pancreatitis	9.36e-06	0.000137	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PPARG—pancreatitis	6.83e-06	0.0001	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—INS—pancreatitis	6.7e-06	9.85e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ALB—pancreatitis	6.14e-06	9.03e-05	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—PTGS2—pancreatitis	5.37e-06	7.9e-05	CbGpPWpGaD
